Ordering Recommendation

Order in conjunction with von Willebrand Factor Activity (Ristocetin Cofactor) (0030250) and Factor VIII, Activity (0030095) as part of initial workup for suspected von Willebrand disease.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lt. blue (sodium citrate). Refer to Specimen Handling at aruplab.com for hemostasis/thrombosis specimen handling guidelines.

Specimen Preparation

Transfer 1.5 mL platelet-poor plasma to an ARUP Standard Transport Tube. (Min: 1 mL)

Storage/Transport Temperature

CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.

Unacceptable Conditions

Serum EDTA plasma, clotted or hemolyzed specimens.

Remarks
Stability

Ambient: 4 hours; Refrigerated: Unacceptable; Frozen at -20°C: 3 months; Frozen at -70°C: 6 months

Methodology

Microlatex Particle-Mediated Immunoassay

Performed

Mon-Sat

Reported

1-3 days

Reference Interval

Age Reference Interval
0-6 years 52-214%
7-9 years 62-180%
10-11 years 63-189%
12-13 years 60-189%
14-15 years 57-199%
16-17 years 50-205%
18 years and older 52-214%

Interpretive Data



Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

85246

Components

Component Test Code* Component Chart Name LOINC
0030285 von Willebrand Factor, Antigen 27816-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Von Willebrand Ag
  • VWF Ag
von Willebrand Factor Antigen